Global Gene Therapy On Cardiovascular Disease Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 94

Published Date: 20 Aug 2021

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Gene Therapy On Cardiovascular Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gene Therapy On Cardiovascular Disease size is estimated to be USD 9 million in 2026 from USD 1 million in 2020, with a change  % between 2020 and 2021. The global Gene Therapy On Cardiovascular Disease market size is expected to grow at a CAGR of 100.9% for the next five years.

Market segmentation
Gene Therapy On Cardiovascular Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Viral Gene Therapy
    Non-Viral Gene Therapy

Market segment by Application, can be divided into
    Heart Disease
    Vascular Disease

Market segment by players, this report covers
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gene Therapy On Cardiovascular Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Therapy On Cardiovascular Disease, with revenue, gross margin and global market share of Gene Therapy On Cardiovascular Disease from 2019 to 2021.
Chapter 3, the Gene Therapy On Cardiovascular Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Gene Therapy On Cardiovascular Disease market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Gene Therapy On Cardiovascular Disease research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy On Cardiovascular Disease
    1.2 Classification of Gene Therapy On Cardiovascular Disease by Type
        1.2.1 Overview: Global Gene Therapy On Cardiovascular Disease Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Type in 2020
        1.2.3 Viral Gene Therapy
        1.2.4 Non-Viral Gene Therapy
    1.3 Global Gene Therapy On Cardiovascular Disease Market by Application
        1.3.1 Overview: Global Gene Therapy On Cardiovascular Disease Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Heart Disease
        1.3.3 Vascular Disease
    1.4 Global Gene Therapy On Cardiovascular Disease Market Size & Forecast
    1.5 Global Gene Therapy On Cardiovascular Disease Market Size and Forecast by Region
        1.5.1 Global Gene Therapy On Cardiovascular Disease Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Gene Therapy On Cardiovascular Disease Market Size by Region, (2016-2021)
        1.5.3 North America Gene Therapy On Cardiovascular Disease Market Size and Prospect (2016-2026)
        1.5.4 Europe Gene Therapy On Cardiovascular Disease Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size and Prospect (2016-2026)
        1.5.6 South America Gene Therapy On Cardiovascular Disease Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Gene Therapy On Cardiovascular Disease Market Drivers
        1.6.2 Gene Therapy On Cardiovascular Disease Market Restraints
        1.6.3 Gene Therapy On Cardiovascular Disease Trends Analysis

2 Company Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Gene Therapy On Cardiovascular Disease Product and Solutions
        2.1.4 Biogen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Biogen Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Gene Therapy On Cardiovascular Disease Product and Solutions
        2.2.4 Novartis Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Product and Solutions
        2.3.4 Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Gilead Sciences Recent Developments and Future Plans
    2.4 Sarepta Therapeutics
        2.4.1 Sarepta Therapeutics Details
        2.4.2 Sarepta Therapeutics Major Business
        2.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.4.4 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.5 Alnylam Pharmaceuticals
        2.5.1 Alnylam Pharmaceuticals Details
        2.5.2 Alnylam Pharmaceuticals Major Business
        2.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product and Solutions
        2.5.4 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Gene Therapy On Cardiovascular Disease Product and Solutions
        2.6.4 Amgen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Spark Therapeutics
        2.7.1 Spark Therapeutics Details
        2.7.2 Spark Therapeutics Major Business
        2.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.7.4 Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Spark Therapeutics Recent Developments and Future Plans
    2.8 Akcea Therapeutics
        2.8.1 Akcea Therapeutics Details
        2.8.2 Akcea Therapeutics Major Business
        2.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.8.4 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Akcea Therapeutics Recent Developments and Future Plans
    2.9 bluebird bio
        2.9.1 bluebird bio Details
        2.9.2 bluebird bio Major Business
        2.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Product and Solutions
        2.9.4 bluebird bio Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 bluebird bio Recent Developments and Future Plans
    2.10 Sunway Biotech
        2.10.1 Sunway Biotech Details
        2.10.2 Sunway Biotech Major Business
        2.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Product and Solutions
        2.10.4 Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Sunway Biotech Recent Developments and Future Plans
    2.11 SIBIONO
        2.11.1 SIBIONO Details
        2.11.2 SIBIONO Major Business
        2.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Product and Solutions
        2.11.4 SIBIONO Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 SIBIONO Recent Developments and Future Plans
    2.12 AnGes
        2.12.1 AnGes Details
        2.12.2 AnGes Major Business
        2.12.3 AnGes Gene Therapy On Cardiovascular Disease Product and Solutions
        2.12.4 AnGes Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 AnGes Recent Developments and Future Plans
    2.13 Orchard Therapeutics
        2.13.1 Orchard Therapeutics Details
        2.13.2 Orchard Therapeutics Major Business
        2.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.13.4 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Orchard Therapeutics Recent Developments and Future Plans
    2.14 Human Stem Cells Institute
        2.14.1 Human Stem Cells Institute Details
        2.14.2 Human Stem Cells Institute Major Business
        2.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product and Solutions
        2.14.4 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy On Cardiovascular Disease Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Gene Therapy On Cardiovascular Disease Players Market Share
        3.2.2 Top 10 Gene Therapy On Cardiovascular Disease Players Market Share
        3.2.3 Market Competition Trend
    3.3 Gene Therapy On Cardiovascular Disease Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Gene Therapy On Cardiovascular Disease Revenue and Market Share by Type (2016-2021)
    4.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Application (2016-2021)
    5.2 Gene Therapy On Cardiovascular Disease Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2026)
    6.2 North America Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2026)
    6.3 North America Gene Therapy On Cardiovascular Disease Market Size by Country
        6.3.1 North America Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2026)
        6.3.2 United States Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        6.3.3 Canada Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        6.3.4 Mexico Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2026)
    7.2 Europe Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2026)
    7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Country
        7.3.1 Europe Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2026)
        7.3.2 Germany Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        7.3.3 France Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        7.3.5 Russia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        7.3.6 Italy Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2026)
    8.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2026)
    8.3 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Region (2016-2026)
        8.3.2 China Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        8.3.3 Japan Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        8.3.4 South Korea Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        8.3.5 India Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        8.3.7 Australia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2026)
    9.2 South America Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2026)
    9.3 South America Gene Therapy On Cardiovascular Disease Market Size by Country
        9.3.1 South America Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2026)
        9.3.2 Brazil Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        9.3.3 Argentina Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2026)
    10.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2026)
    10.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2026)
        10.3.2 Turkey Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)
        10.3.4 UAE Gene Therapy On Cardiovascular Disease Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy On Cardiovascular Disease Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Gene Therapy On Cardiovascular Disease Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Gene Therapy On Cardiovascular Disease Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Gene Therapy On Cardiovascular Disease Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Region (2021-2026)
    Table 6. Biogen Corporate Information, Head Office, and Major Competitors
    Table 7. Biogen Major Business
    Table 8. Biogen Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 9. Biogen Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Novartis Corporate Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 13. Novartis Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors
    Table 15. Gilead Sciences Major Business
    Table 16. Gilead Sciences Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 17. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 19. Sarepta Therapeutics Major Business
    Table 20. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 21. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 23. Alnylam Pharmaceuticals Major Business
    Table 24. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 25. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Amgen Corporate Information, Head Office, and Major Competitors
    Table 27. Amgen Major Business
    Table 28. Amgen Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 29. Amgen Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 31. Spark Therapeutics Major Business
    Table 32. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 33. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Akcea Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 35. Akcea Therapeutics Major Business
    Table 36. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 37. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. bluebird bio Corporate Information, Head Office, and Major Competitors
    Table 39. bluebird bio Major Business
    Table 40. bluebird bio Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 41. bluebird bio Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Sunway Biotech Corporate Information, Head Office, and Major Competitors
    Table 43. Sunway Biotech Major Business
    Table 44. Sunway Biotech Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 45. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. SIBIONO Corporate Information, Head Office, and Major Competitors
    Table 47. SIBIONO Major Business
    Table 48. SIBIONO Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 49. SIBIONO Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. AnGes Corporate Information, Head Office, and Major Competitors
    Table 51. AnGes Major Business
    Table 52. AnGes Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 53. AnGes Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Orchard Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 55. Orchard Therapeutics Major Business
    Table 56. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 57. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Human Stem Cells Institute Corporate Information, Head Office, and Major Competitors
    Table 59. Human Stem Cells Institute Major Business
    Table 60. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 61. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Global Gene Therapy On Cardiovascular Disease Revenue (USD Million) by Players (2019-2021)
    Table 63. Global Gene Therapy On Cardiovascular Disease Revenue Share by Players (2019-2021)
    Table 64. Breakdown of Gene Therapy On Cardiovascular Disease by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Gene Therapy On Cardiovascular Disease Players Head Office, Products and Services Provided
    Table 66. Gene Therapy On Cardiovascular Disease Mergers & Acquisitions in the Past Five Years
    Table 67. Gene Therapy On Cardiovascular Disease New Entrants and Expansion Plans
    Table 68. Global Gene Therapy On Cardiovascular Disease Revenue (USD Million) by Type (2016-2021)
    Table 69. Global Gene Therapy On Cardiovascular Disease Revenue Share by Type (2016-2021)
    Table 70. Global Gene Therapy On Cardiovascular Disease Revenue Forecast by Type (2021-2026)
    Table 71. Global Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2021)
    Table 72. Global Gene Therapy On Cardiovascular Disease Revenue Forecast by Application (2021-2026)
    Table 73. North America Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2021) & (USD Million)
    Table 74. North America Gene Therapy On Cardiovascular Disease Revenue by Type (2021-2026) & (USD Million)
    Table 75. North America Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2021) & (USD Million)
    Table 76. North America Gene Therapy On Cardiovascular Disease Revenue by Application (2021-2026) & (USD Million)
    Table 77. North America Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2021) & (USD Million)
    Table 78. North America Gene Therapy On Cardiovascular Disease Revenue by Country (2021-2026) & (USD Million)
    Table 79. Europe Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2021) & (USD Million)
    Table 80. Europe Gene Therapy On Cardiovascular Disease Revenue by Type (2021-2026) & (USD Million)
    Table 81. Europe Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2021) & (USD Million)
    Table 82. Europe Gene Therapy On Cardiovascular Disease Revenue by Application (2021-2026) & (USD Million)
    Table 83. Europe Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2021) & (USD Million)
    Table 84. Europe Gene Therapy On Cardiovascular Disease Revenue by Country (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Type (2021-2026) & (USD Million)
    Table 87. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2021) & (USD Million)
    Table 88. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Application (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Region (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue by Region (2021-2026) & (USD Million)
    Table 91. South America Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2021) & (USD Million)
    Table 92. South America Gene Therapy On Cardiovascular Disease Revenue by Type (2021-2026) & (USD Million)
    Table 93. South America Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2021) & (USD Million)
    Table 94. South America Gene Therapy On Cardiovascular Disease Revenue by Application (2021-2026) & (USD Million)
    Table 95. South America Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2021) & (USD Million)
    Table 96. South America Gene Therapy On Cardiovascular Disease Revenue by Country (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Type (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Type (2021-2026) & (USD Million)
    Table 99. Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Application (2016-2021) & (USD Million)
    Table 100. Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Application (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Country (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Gene Therapy On Cardiovascular Disease Picture
    Figure 2. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Type in 2020
    Figure 3. Viral Gene Therapy
    Figure 4. Non-Viral Gene Therapy
    Figure 5. Gene Therapy On Cardiovascular Disease Revenue Market Share by Application in 2020
    Figure 6. Heart Disease Picture
    Figure 7. Vascular Disease Picture
    Figure 8. Global Gene Therapy On Cardiovascular Disease Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 9. Global Gene Therapy On Cardiovascular Disease Revenue and Forecast (2016-2026) & (USD Million)
    Figure 10. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Region (2016-2026)
    Figure 11. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Region in 2020
    Figure 12. North America Gene Therapy On Cardiovascular Disease Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 13. Europe Gene Therapy On Cardiovascular Disease Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. South America Gene Therapy On Cardiovascular Disease Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Middle East and Africa Gene Therapy On Cardiovascular Disease Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Gene Therapy On Cardiovascular Disease Market Drivers
    Figure 18. Gene Therapy On Cardiovascular Disease Market Restraints
    Figure 19. Gene Therapy On Cardiovascular Disease Market Trends
    Figure 20. Biogen Recent Developments and Future Plans
    Figure 21. Novartis Recent Developments and Future Plans
    Figure 22. Gilead Sciences Recent Developments and Future Plans
    Figure 23. Sarepta Therapeutics Recent Developments and Future Plans
    Figure 24. Alnylam Pharmaceuticals Recent Developments and Future Plans
    Figure 25. Amgen Recent Developments and Future Plans
    Figure 26. Spark Therapeutics Recent Developments and Future Plans
    Figure 27. Akcea Therapeutics Recent Developments and Future Plans
    Figure 28. bluebird bio Recent Developments and Future Plans
    Figure 29. Sunway Biotech Recent Developments and Future Plans
    Figure 30. SIBIONO Recent Developments and Future Plans
    Figure 31. AnGes Recent Developments and Future Plans
    Figure 32. Orchard Therapeutics Recent Developments and Future Plans
    Figure 33. Human Stem Cells Institute Recent Developments and Future Plans
    Figure 34. Global Gene Therapy On Cardiovascular Disease Revenue Share by Players in 2020
    Figure 35. Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 36. Global Top 3 Players Gene Therapy On Cardiovascular Disease Revenue Market Share in 2020
    Figure 37. Global Top 10 Players Gene Therapy On Cardiovascular Disease Revenue Market Share in 2020
    Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 39. Global Gene Therapy On Cardiovascular Disease Revenue Share by Type in 2020
    Figure 40. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Type (2021-2026)
    Figure 41. Global Gene Therapy On Cardiovascular Disease Revenue Share by Application in 2020
    Figure 42. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Application (2021-2026)
    Figure 43. North America Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2016-2026)
    Figure 44. North America Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2016-2026)
    Figure 45. North America Gene Therapy On Cardiovascular Disease Revenue Market Share by Country (2016-2026)
    Figure 46. United States Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Canada Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Mexico Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Europe Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2016-2026)
    Figure 50. Europe Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2016-2026)
    Figure 51. Europe Gene Therapy On Cardiovascular Disease Revenue Market Share by Country (2016-2026)
    Figure 52. Germany Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. France Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. United Kingdom Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Russia Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Italy Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Asia-Pacific Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2016-2026)
    Figure 58. Asia-Pacific Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2016-2026)
    Figure 59. Asia-Pacific Gene Therapy On Cardiovascular Disease Revenue Market Share by Region (2016-2026)
    Figure 60. China Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Japan Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South Korea Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. India Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Southeast Asia Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Australia Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South America Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2016-2026)
    Figure 67. South America Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2016-2026)
    Figure 68. South America Gene Therapy On Cardiovascular Disease Revenue Market Share by Country (2016-2026)
    Figure 69. Brazil Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Argentina Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2016-2026)
    Figure 72. Middle East and Africa Gene Therapy On Cardiovascular Disease Sales Market Share by Application (2016-2026)
    Figure 73. Middle East and Africa Gene Therapy On Cardiovascular Disease Revenue Market Share by Country (2016-2026)
    Figure 74. Turkey Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Saudi Arabia Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. UAE Gene Therapy On Cardiovascular Disease Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Related Reports

Global Gene Therapy On Cardiovascular Disease Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Gene Therapy On Cardiovascular Disease Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Medical Devices & Consumables

The Gene Therapy On Cardiovascular Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Gene Therapy On Cardiovascular Disease Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Gene Therapy On Cardiovascular Disease Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Devices & Consumables

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Global Gene Therapy On Cardiovascular Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gene Therapy On Cardiovascular Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Gene Therapy On Cardiovascular Disease market size was valued at USD 13 million in 2023 and is forecast to a readjusted size of USD 1073.1 million by 2030 with a CAGR of 87.1% during review period.

Product Tags

gene therapy on cardiovascular disease

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>